Secondary stroke prevention in very elderly patients [3];Prevención secundaria del ictus en pacientes muy ancianos

Revista de Neurologia

Volumn 43, Issue 2, 2006, Pages 124-125

  Castilla Guerra, Luis ^a,d   Fernandez Moreno M C ^c   Espino Montoro, A ^a   Lopez Chozas J M ^b   Jimenez M D ^b  

^a HOSPITAL DE LA MERCED   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; INSULIN;

DIABETES MELLITUS; DYSLIPIDEMIA; GELASTIC SEIZURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; LETTER; OBESITY; AGED; CEREBROVASCULAR ACCIDENT; FEMALE; MIDDLE AGED; RECURRENT DISEASE; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 33750105060     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4302.2006009     Document Type: Letter

References (14)

1. Instituto Nacional de Estadística. URL: http://www.ine.es/prensa/ np313.pdf. Fecha última consulta: 26.12.2003.
2. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention. JAMA 2002; 288: 1388-95.
3. Hankey GJ. Secondary prevention of recurrent stroke. Stroke 2005; 36: 218-21.
4. Ramírez-Lassepas M. Stroke and the aging of the brain and arteries. Geriatrics 1998; 53: 44-9.
5. Broderick JP. William M. Feinberg lecture: stroke therapy in the year 2025. Burden, breakthroughs, and barriers to progress. Stroke 2004; 35: 205-11.
6. Hart RG, Halperin JL. Atrial fibrillation and stroke. Stroke 2001; 32: 803-16.
7. Mehta NN, Greenspon AJ. Atrial fibrillation. Rhythm versus rate control. Geriatrics 2003; 58: 39-44.
8. Man-Son-Hing M, Nichol G, Lau A, et al. Choosing antithrobotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 1999; 159: 677-85.
9. SPARCL Investigators. Design and baseline characteristics of the Stroke Prevention by Agressive Reduction in Cholesterol Levels Study. Cerebrovasc Dis 2003; 16: 389-95.
10. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo controlled trial. Lancet 2002; 360: 7-22.
11. Amarenco P, Tonkin AM. Statins for stroke prevention. Disappointment and hope. Circulation 2004; 109: 44-9.
12. Nash DT. Statins. Evidence of effectiveness in older patients. Geriatrics 2003; 58: 35-42.
13. Eimer MJ, Stone NJ. Evidence-based treatment of lipids in the elderly. Curr Atheroscler Rep 2004; 6: 388-97.
14. Grundy SM, Cleeman JI, Merz CN, Brener HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39.